Trademarkia Logo

Canada

C$
Trademark Search in Canada
FLEXISEQ

View On IC.GC.CA

FLEXISEQ
REGISTERED

on 13 Oct 2021

Last Applicant/ Owned by

PRO BONO BIO ENTREPRENEUR LIMITED

4th Floor, Reading Bridge HouseGeorge StreetReading, Berkshire RG1 8LS

GB

Serial Number

1906860 filed on 28th Jun 2018

Registration Number

TMA1111476 registered on 13th Oct 2021

Registration expiry Date

13th Oct 2031

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

FLEXISEQ

Trademark usage description

chemical preparations for pharmaceutical purposes for the treatment of pain, osteoarthritis and inflammatory diseases, namely, rheumatoid arthritis, g Read More

Classification Information

Class [005]
Chemical preparations for pharmaceutical purposes for the treatment of pain, osteoarthritis and inflammatory diseases, namely, rheumatoid arthritis, gout, and lupus, for human and veterinary use; chemical preparations for use as additives for pharmaceutical preparations for the treatment of pain, osteoarthritis and inflammatory diseases, namely, rheumatoid arthritis, gout, and lupus, for human and veterinary use; delivery agents in the form of vesicles and liposomes that facilitate the delivery of chemical and pharmaceutical preparations for the treatment of pain, osteoarthritis and inflammatory diseases, namely, rheumatoid arthritis, gout, and lupus, for human and veterinary use; chemical preparation for pharmaceutical purposes, namely, CBD oil for the treatment of anxiety disorder and depression; pharmaceuticals for the treatment and prevention of osteoarthritis, inflammatory diseases, namely, rheumatoid arthritis, gout, lupus, joint and musculoskeletal pain, and central nervous system diseases, namely, nervous disorders, neurosis, anxiety, depression, epilepsy, Parkinson's disease; topical and parenteral preparations of vesicles being liposomes, namely in the nature of anti-inflammatory preparations; chemical membranes and chemical aggregates for medical and veterinary purposes, namely, pain relief medication, and anti-inflammatory preparations; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical, cosmetic and veterinary substances, namely pain relief medication, anti-inflammatory preparations, and treatment for dermatological conditions, namely, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, acne vulgaris; cosmeceutical preparations for therapeutic purposes, namely, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution containing lipidic vesicles for the treatment of dermatological conditions, namely, acne, rosacea, eczema, seborrheic dermatitis, damaged skin, psoriasis; liposomes for topical and parenteral use in the form of pain relief medication and anti-inflammatory preparations for the upper dermal layers; pain relief medication and anti-inflammatories, namely in the form of creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution; surfactants for therapeutic use in the treatment and prevention of inflammatory diseases, namely, arthritis, and dermatological conditions, namely, acne, rosacea, eczema, seborrheic dermatitis, damaged skin, psoriasis; Medical devices for topical use in the treatment of pain, namely, topical gels and creams containing liposomes for pain relief, delivery agents in the form of liposomes that facilitate the delivery of pain relief preparations, liposomes loaded with anti-inflammatories and pain relief preparations for topical use; medical apparatus, namely, topically applied gel, cream, and dispersions containing nanostructures for the treatment of joint pain and arthritis.

Classification kind code

11

Class [010]
Medical and veterinary devices

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

1906860

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 30th Jun 2021		Advertised
Submitted for opposition 27
on 7th Jun 2021		Approval Notice Sent
Submitted for opposition 26
on 7th Jun 2021		Approved
Submitted for opposition 15
on 3rd Feb 2021		Correspondence Created
Submitted for opposition 22
on 24th Jul 2020		Search Recorded
Submitted for opposition 20
on 24th Jul 2020		Examiner's First Report
Submitted for opposition 67
on 11th Sept 2019		Agent Name Changed
Submitted for opposition 31
on 4th Jul 2018		Formalized
Submitted for opposition 1
on 29th Jun 2018		Created
Submitted for opposition 30
on 28th Jun 2018		Filed